Welcome to CR Ventures

CR Ventures is a global life-science investor with a focus on companies aiming to fund clinical trials for pharmaceuticals, diagnostics, and other medical technologies. CR Ventures funds up to 10 clinical programs per year, utilizing a unique investment structure. CR Ventures offers biotech and medtech companies and their existing investors, more control, less total dilution, and faster results.

CR Ventures partners with a top-tier clinical research organization to achieve rapid start-up, enrollment and successful trial completion in a time and capital efficient manner for our portfolio companies. Our partner has completed over 200 Phase I to III trials for Pfizer, Novartis, Merck (American), GSK, Amgen, AstraZeneca, and others, and an excellent track record for rapid patient enrollment, high retention, and industry-leading success rates.

CR Ventures has offices in Boston and Europe, and invests world-wide. Companies seeking investment are invited to Start Here. Interested companies and co-investors may also contact us at contactus@cr-ventures.com.

Clinical Research Ventures